Immuneering Corporation
IMRX
$1.54
$0.096.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.05M | -18.05M | -14.60M | -14.08M | -14.31M |
| Total Depreciation and Amortization | 92.60K | 93.40K | 96.30K | 97.80K | 97.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.78M | 1.76M | 1.69M | 1.73M | 1.40M |
| Change in Net Operating Assets | -902.50K | 1.69M | -657.60K | 724.50K | -2.68M |
| Cash from Operations | -14.08M | -14.51M | -13.47M | -11.53M | -15.49M |
| Capital Expenditure | -8.90K | -9.40K | -5.30K | -32.80K | -37.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 5.50M | -5.41M | 5.00M | 21.43M |
| Cash from Investing | -8.90K | 5.49M | -5.42M | 4.97M | 21.39M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13.81M | 86.40K | 4.36M | 0.00 | 979.90K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -127.40K | -- | -- | -- |
| Cash from Financing | 13.81M | -41.00K | 4.36M | 0.00 | 979.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -279.00K | -9.06M | -14.52M | -6.56M | 6.88M |